Security key
14817C107
FILANA THERAPEUTICS, INC. - Common Stock (FLNA)
CUSIP: 14817C107
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 13,778,326
- Total 13F value
- $40,074,441
- Share change
- +1,616,809
- Put/Call ratio
- 38%
- SEC-reported price per share
- $2.91
- Number of holders
- 101
- Value change
- +$5,040,034
- Number of buys
- 39
- Number of sells
- 44
- Shares outstanding
- 48,331,225
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
101
Top holders
10
FLNA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
FILANA THERAPEUTICS, INC. SEC filings
FILANA THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 14817C107
Recent filing periods:
Ownership snapshot
Top reported holders of FLNA - FILANA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Nachtrab Matthew
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
13F
Lead comparable stake: 4.7%
13D/G row: Nachtrab Matthew
Showing 1-6 of 15 holder rows.
Quick read
Nachtrab Matthew leads the comparable SEC ownership view at 4.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Nachtrab Matthew's linked filing trail.
Comparable ownership
Top 5
Nachtrab Matthew
4.7%
VANGUARD GROUP INC
4.5%
BlackRock, Inc.
3.2%
TWO SIGMA ADVISERS, LP
2%
JPMORGAN CHASE & CO
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Nachtrab Matthew |
13D/G
|
4.7%
|
$3,560,189
2,267,636 shares
|
$0 | 16 Aug 2024 |
| VANGUARD GROUP INC |
13F
13D/G
Company · The Vanguard Group
|
4.5%
from 13D/G
|
$3,927,831
2,170,072 shares
|
— | 30 Jun 2025 |
| BlackRock, Inc. |
13F
13D/G
Company
|
3.2%
from 13D/G
|
$2,798,093
1,545,907 shares
|
— | 30 Jun 2025 |
| TWO SIGMA ADVISERS, LP |
13F
Company
|
2%
|
$1,780,316
983,600 shares
|
— | 30 Jun 2025 |
| JPMORGAN CHASE & CO |
13F
Company
|
1.6%
|
$1,370,281
757,061 shares
|
— | 30 Jun 2025 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
1.3%
|
$1,109,788
613,143 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
101
Shares
13,778,326
Rows available
101
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
96
Q3 2025 holders
101
Holder diff
5
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend